AzurRx BioPharma (AZRX) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free AZRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 11, 2024 | seekingalpha.comYS YS Biopharma Co., Ltd.April 19, 2023 | finance.yahoo.comHanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship ProgramJanuary 15, 2023 | marketwatch.comFirst Wave BioPharma Shares Jump 21% on FDA Review of Adrulipase IND FilingSeptember 16, 2022 | seekingalpha.comFWBI First Wave BioPharma, Inc.April 30, 2022 | investing.comFirst Wave BioPharma Inc (FWBI)October 1, 2021 | reuters.comFirst Wave BioPharma IncSeptember 21, 2021 | marketwatch.comAzurRx BioPharma Changes Name to First Wave BioPharmaSeptember 21, 2021 | finance.yahoo.comAzurRx BioPharma to Change Corporate Name to First Wave BioPharma TodaySeptember 14, 2021 | benzinga.comAzurRx BioPharma To Acquire First Wave Bio In Transformative $229 Million Deal; Significantly Expands GI and IBD Treatment Pipeline (NASDAQ: AZRX)September 14, 2021 | msn.comWhy AzurRx BioPharma's Stock Is Trading Higher TodaySeptember 14, 2021 | finance.yahoo.comAzurRx (AZRX) Announces First Wave Bio Acquisition for $229MSeptember 14, 2021 | marketbeat.comTrading was temporarily halted for "AZRX" at 09:09 AM with a stated reason of "LULD pause."September 14, 2021 | apnews.comAzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave ...September 14, 2021 | finance.yahoo.comAzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharmaSeptember 13, 2021 | finance.yahoo.comAzurRx BioPharma To Acquire First Wave Bio For $229MSeptember 13, 2021 | nasdaq.comAzurRx Announces Acquisition Of First Wave Bio, And Creation Of First Wave BioPharmaSeptember 13, 2021 | finanznachrichten.deAzurRx BioPharma, Inc.: AzurRx BioPharma Announces Reverse Stock SplitSeptember 13, 2021 | finance.yahoo.comAzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease IndicationsSeptember 10, 2021 | finance.yahoo.comAzurRx BioPharma Announces Reverse Stock SplitSeptember 10, 2021 | apnews.comAzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial ...September 10, 2021 | nasdaq.comAzurRx Activates New Clinical Trial Sites In India For Gastrointestinal Infections COVID-19 StudySeptember 10, 2021 | finance.yahoo.comAzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsSeptember 9, 2021 | markets.businessinsider.comDMC Recommends AzurRx Continues Gastrointestinal Infections COVID-19 StudySeptember 9, 2021 | finance.yahoo.comAzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsSeptember 8, 2021 | finance.yahoo.comAzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as Treatment for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-Associated ColitisSeptember 7, 2021 | ca.finance.yahoo.comAzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 7, 2021 | finance.yahoo.comAzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 5, 2021 | fool.comAZURRX BIOPHARMA INC COM USD0.0001(AZRX)August 18, 2021 | marketwatch.comAzurRx BioPharma Shares Rally on MS1819 Study Results >AZRXAugust 18, 2021 | finance.yahoo.comWhy AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?August 18, 2021 | apnews.comAzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial ...August 18, 2021 | finance.yahoo.comAzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)August 17, 2021 | finance.yahoo.comAzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819August 12, 2021 | finance.yahoo.comAzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsAugust 10, 2021 | finance.yahoo.comAzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsJuly 28, 2021 | apnews.comAzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full ...July 24, 2021 | benzinga.comAzurRx BioPharma shares are trading lower after the company announced it increased its previously announced bought deal offering to $5 million.July 23, 2021 | nasdaq.comAzurRx BioPharma, Inc. Common Stock (AZRX)July 22, 2021 | finance.yahoo.comAzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 MillionJuly 22, 2021 | finance.yahoo.comAzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide AZRX Media Mentions By Week AZRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZRX News Sentiment▼0.000.54▲Average Medical News Sentiment AZRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZRX Articles This Week▼00▲AZRX Articles Average Week Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LUMO News QLI News ONCT News LSTA News ITRM News TXMD News FBRX News BFRG News GDTC News CPIX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZRX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AzurRx BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
